bludigo
Generic: indigotindisulfonate sodium
Labeler: provepharm inc.Drug Facts
Product Profile
Brand Name
bludigo
Generic Name
indigotindisulfonate sodium
Labeler
provepharm inc.
Dosage Form
INJECTION
Routes
Active Ingredients
indigotindisulfonate sodium 8 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
81284-315
Product ID
81284-315_2d60b6a4-17d2-4864-b01c-9862283da8de
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA216264
Listing Expiration
2026-12-31
Marketing Start
2022-09-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
81284315
Hyphenated Format
81284-315
Supplemental Identifiers
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bludigo (source: ndc)
Generic Name
indigotindisulfonate sodium (source: ndc)
Application Number
NDA216264 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 8 mg/mL
Packaging
- 5 AMPULE in 1 CARTON (81284-315-05) / 5 mL in 1 AMPULE (81284-315-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2d60b6a4-17d2-4864-b01c-9862283da8de", "openfda": {"upc": ["0381284315050"], "unii": ["D3741U8K7L"], "spl_set_id": ["73f246c4-b127-452e-856f-134b56cb8870"], "manufacturer_name": ["Provepharm Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 AMPULE in 1 CARTON (81284-315-05) / 5 mL in 1 AMPULE (81284-315-00)", "package_ndc": "81284-315-05", "marketing_start_date": "20220906"}], "brand_name": "BLUDIGO", "product_id": "81284-315_2d60b6a4-17d2-4864-b01c-9862283da8de", "dosage_form": "INJECTION", "pharm_class": ["Diagnostic Dye [EPC]", "Dyes [MoA]"], "product_ndc": "81284-315", "generic_name": "indigotindisulfonate sodium", "labeler_name": "Provepharm Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BLUDIGO", "active_ingredients": [{"name": "INDIGOTINDISULFONATE SODIUM", "strength": "8 mg/mL"}], "application_number": "NDA216264", "marketing_category": "NDA", "marketing_start_date": "20220906", "listing_expiration_date": "20261231"}